HORIZON-HLTH-2024-DISEASE-03-two-stage
HORIZON-HLTH-2024-DISEASE-03-two-stage
- Programme
- HORIZON
- Funded projects (dataset)
- 17
- EU contribution (sum)
- €143,006,648
- Portal deadline
- —
Leading topic in historical projects: HORIZON-HLTH-2024-DISEASE-03-08-two-stage
Start here
Suggested partners for this call
Who coordinated consortia under this call, plus a complementary slice (topic leaders, research partners, or frequent non-coordinators). For industry lists, CSV export, and consortium size — open Proposal partner finder.
Top coordinators
Organisations that coordinated the most funded projects under this call.
- INSERM2 coordinated
- AIDFM1 coordinated
- ERASMUS MC1 coordinated
- FONDAZIONE PENTA ETS1 coordinated
- HUNIMED1 coordinated
- IRSANTPAU CERCA1 coordinated
- LINKCARE1 coordinated
- NORCE1 coordinated
- OUS1 coordinated
- TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY1 coordinated
- UNICANCER1 coordinated
- UKE1 coordinated
Organisations strong on this topic
Broader signal: frequent participants across funded projects tagged with the same topic codes as this call (not limited to coordinators).
- KI3 topic projects
- UZH3 topic projects
- LEITAT2 topic projects
- AE2 topic projects
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2 topic projects
- CLINIQUES UNIVERSITAIRES SAINT-LUC ASBL2 topic projects
- IDIBAPS-CERCA2 topic projects
- HOSPITAL CLINIC DE BARCELONA2 topic projects
- HUMANITAS MIRASOLE SPA2 topic projects
- UNIVERSITY OF EASTERN FINLAND (UEF)2 topic projects
- MLU2 topic projects
- SAS2 topic projects
Frequent collaborators
Pairs that often appear together in the same funded project under this call.
- UNIVERSITY COLLEGE LONDON · INSERM2 shared
UK ↔ FR
- SORBONNE UNIVERSITE · SERMAS2 shared
FR ↔ ES
- 2 shared
- UNIVERSITY COLLEGE LONDON · SERMAS2 shared
UK ↔ ES
- 2 shared
- 2 shared
- MLU · UNIVERSITY OF EASTERN FINLAND (UEF)2 shared
DE ↔ FI
- KI · UNIVERSITAT BASEL2 shared
SE ↔ CH
- MEDIZINISCHE UNIVERSITAET WIEN · UNIVR2 shared
AT ↔ IT
- OLLSCOIL NA GAILLIMHE · SERMAS2 shared
IE ↔ ES
- UNIVERSITY COLLEGE LONDON · UANTWERPEN2 shared
UK ↔ BE
- UNIVERSITY COLLEGE LONDON · UNIVR2 shared
UK ↔ IT
- 2 shared
- 2 shared
- HUMANITAS MIRASOLE SPA · KI2 shared
IT ↔ SE
- HUMANITAS MIRASOLE SPA · UNIVERSITAT BASEL2 shared
IT ↔ CH
- 2 shared
- SORBONNE UNIVERSITE · NWO-I2 shared
FR ↔ NL
Proposal partner finder
One page with suggested coordinators, strong and industry partners, topic leaders, typical consortium size, similar projects — plus CSV or print / PDF export for your shortlist.
Typical consortium pattern
Derived from historical funded projects linked to this CORDIS call in Grantibase.
- Avg. orgs / project
- 17.41
- Median orgs / project
- 16
- Min / max orgs
- 9 – 27
Country presence
Participant rows (an org can appear in multiple countries if data varies).
- Spain35
- Italy33
- France32
- Germany25
- Netherlands20
- Belgium19
- United Kingdom19
- Norway14
- Switzerland11
- Austria9
- Poland9
- Finland7
- Portugal7
- Greece6
- Sweden6
- Ireland5
- Israel5
- Australia4
Organization types
- university100 orgs · 123 rows
- research_institute66 orgs · 78 rows
- other33 orgs · 34 rows
- sme29 orgs · 29 rows
- public_body13 orgs · 17 rows
- company13 orgs · 15 rows
Topics in funded projects
- HORIZON-HLTH-2024-DISEASE-03-08-two-stageHORIZON-HLTH-2024-DISEASE-03-08-two-stage· 7 projects
- HORIZON-HLTH-2024-DISEASE-03-13-two-stageHORIZON-HLTH-2024-DISEASE-03-13-two-stage· 4 projects
- HORIZON-HLTH-2024-DISEASE-03-14-two-stageHORIZON-HLTH-2024-DISEASE-03-14-two-stage· 4 projects
- HORIZON-HLTH-2024-DISEASE-03-11-two-stageHORIZON-HLTH-2024-DISEASE-03-11-two-stage· 2 projects
Related funded projects
Largest EU contributions in this call — useful to see who already won funding on similar lines.
Open full project list in advanced search
| Project | Programme | EU contribution |
|---|---|---|
| PROACT EU-Response A European Proactive Adaptive Clinical Trials Network within EU-Response | HORIZON | €17,042,172 |
| PIPELINE Pregnancy and Infant PrEparedness pLatform IN Europe | HORIZON | €9,999,975 |
| PATH-FOR-YOUNG Personalized Adjuvant Treatment for HR+/HER2- breast cancer FOR YOUNG patients | HORIZON | €9,498,604 |
| FALCO Fighting Addictions, improving Lives: COmprehensive drug rehabilitation with music | HORIZON | €8,995,781 |
| YOUTHreach Bridging Gaps in Mental Health Support: A Comprehensive European Strategy | HORIZON | €8,501,477 |
| PREDICTFTD Accelerating the Validation of Predictive Liquid Biomarkers for Frontotemporal Dementia Diagnosis and Subclassification | HORIZON | €7,994,911 |
| VOLABIOS Validation and Comparitive Multi-Omics Benchmarking of Fluid-Derived Volatilomics Biomarkers for the Prevention and Early detection of Schizophrenia | HORIZON | €7,988,083 |
| VaMPiRE Validation of α-synuclein Modifications in Parkinson’s dIsoRder Evolution | HORIZON | €7,928,633 |
| FluiDx-AD A novel test trio to detect peptide biomarkers in saliva and blood for enhanced diagnosis and management of Alzheimer's Disease | HORIZON | €7,699,219 |
| IMPROVE PRETERM IMPROVing lifElong health and development for children and adults born very PRETERM – observational studies to enhance randomised trials for comparative effectiveness research | HORIZON | €7,668,748 |
| MDR-RA Defining Clinical and Molecular Phenotypes of Multi-Drug Resistance in difficult to treat Rheumatoid Arthritis | HORIZON | €7,430,427 |
| FH-EARLY NEW STRATEGIES FOR THE EARLY DIAGNOSIS, RISK STRATIFICATION AND CO-MANAGEMENT OF FAMILIAL HYPERCHOLESTEROLEMIA | HORIZON | €7,286,252 |
| SGLT2-HYPE SGLT2 INHIBITION FOR CARDIOVASCULAR ENDPOINT REDUCTION IN HYPERTENSION (SGLT2-HYPE) | HORIZON | €6,999,999 |
| ECOPOP EARLY COLORECTAL CANCER: PATIENT-TARGETED AND ORGAN PRESERVING TREATMENT ECOPOP | HORIZON | €6,999,931 |
| SYNAPSING Synapsing Mental Disorders and Neurodegenerative diseases: Towards more effective diagnosis and management of psychiatric symptoms | HORIZON | €6,999,922 |